These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Development of the RTS,S/AS malaria candidate vaccine. Vekemans J; Leach A; Cohen J Vaccine; 2009 Dec; 27 Suppl 6():G67-71. PubMed ID: 20006143 [TBL] [Abstract][Full Text] [Related]
5. Phase 1 safety and immunogenicity trial of malaria vaccine RTS,S/AS02A in adults in a hyperendemic region of western Kenya. Stoute JA; Heppner DG; Mason CJ; Siangla J; Opollo MO; Kester KE; Vigneron L; Voss G; Walter MJ; Tornieporth N; Cohen JD; Ballou WR Am J Trop Med Hyg; 2006 Jul; 75(1):166-70. PubMed ID: 16837726 [TBL] [Abstract][Full Text] [Related]
6. RTS,S/AS02A for malaria. Bojang KA Expert Rev Vaccines; 2006 Oct; 5(5):611-5. PubMed ID: 17181435 [TBL] [Abstract][Full Text] [Related]
7. Malaria vaccine gets shot in the arm from tests. Maher B Nature; 2008 Dec; 456(7223):680-1. PubMed ID: 19079013 [No Abstract] [Full Text] [Related]
8. Vaccine development against malaria. Matuschewski K Curr Opin Immunol; 2006 Aug; 18(4):449-57. PubMed ID: 16765576 [TBL] [Abstract][Full Text] [Related]
9. Methods for determining vaccine efficacy and effectiveness and the main barriers to developing a fully deployable malaria vaccine. Guinovart C; Alonso PL Am J Trop Med Hyg; 2007 Dec; 77(6 Suppl):276-81. PubMed ID: 18165503 [TBL] [Abstract][Full Text] [Related]
10. Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naïve adults at the Walter Reed Army Institute of Research. Kester KE; Cummings JF; Ockenhouse CF; Nielsen R; Hall BT; Gordon DM; Schwenk RJ; Krzych U; Holland CA; Richmond G; Dowler MG; Williams J; Wirtz RA; Tornieporth N; Vigneron L; Delchambre M; Demoitie MA; Ballou WR; Cohen J; Heppner DG; Vaccine; 2008 Apr; 26(18):2191-202. PubMed ID: 18387719 [TBL] [Abstract][Full Text] [Related]
11. Progress towards the development of malaria vaccines. Malkin E; Dubovsky F; Moree M Trends Parasitol; 2006 Jul; 22(7):292-5. PubMed ID: 16707275 [TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of the RTS,S/AS02A candidate malaria vaccine in children aged 1-4 in Mozambique. Macete E; Aponte JJ; Guinovart C; Sacarlal J; Ofori-Anyinam O; Mandomando I; Espasa M; Bevilacqua C; Leach A; Dubois MC; Heppner DG; Tello L; Milman J; Cohen J; Dubovsky F; Tornieporth N; Thompson R; Alonso PL Trop Med Int Health; 2007 Jan; 12(1):37-46. PubMed ID: 17207146 [TBL] [Abstract][Full Text] [Related]
14. Safety of the RTS,S/AS02A malaria vaccine in Mozambican children during a Phase IIb trial. Sacarlal J; Aponte JJ; Aide P; Mandomando I; Bassat Q; Guinovart C; Leach A; Milman J; Macete E; Espasa M; Ofori-Anyinam O; Thonnard J; Corachan S; Dubois MC; Lievens M; Dubovsky F; Ballou WR; Cohen J; Alonso PL Vaccine; 2008 Jan; 26(2):174-84. PubMed ID: 18069097 [TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of rts,s+trap malaria vaccine, formulated in the as02a adjuvant system, in infant rhesus monkeys. Walsh DS; Pichyangkul S; Gettayacamin M; Tongtawe P; Siegrist CA; Hansukjariya P; Kester KE; Holland CA; Voss G; Cohen J; Stewart AV; Miller RS; Ballou WR; Heppner DG Am J Trop Med Hyg; 2004 May; 70(5):499-509. PubMed ID: 15155981 [TBL] [Abstract][Full Text] [Related]
16. Challenges in malaria control in sub-Saharan Africa: the vaccine perspective. Lusingu JP; Von Seidlein L Tanzan J Health Res; 2008 Oct; 10(4):253-66. PubMed ID: 19402588 [TBL] [Abstract][Full Text] [Related]